Both compounds effectively induced concentration-dependent degradation of the EGFRDel19 mutant and inhibited p-EGFR in HCC-827 cells, with MS9449 showing approximately 10-fold greater potency than MS9427. This evidence concerns the gene EGFR and hepatocellular carcinoma.